China
China Articles
Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight against COVID-19.
Published:
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Published:
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Published:
In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here, 24/7 Wall St. has picked out some of Wedbush’s top picks within...
Published:
Apple is extending the closure of its U.S. stores and work-from-home procedures will stay in place until early May due to the ongoing coronavirus pandemic.
Published:
Luckin Coffee shares cratered on Thursday after the company announced that it has formed a committee of three independent directors to investigate internal misconduct.
Published:
With its massive exposure to China and global footprint, Nike was definitely hurt by the coronavirus, but earnings demonstrated why this company is strong.
Published:
Nike released mixed fiscal third-quarter financial results late on Tuesday, but shares were sharply higher early Wednesday.
Published:
No industry has been safe from the market carnage due to the coronavirus pandemic. It’s uncertain if a bottom is in sight yet, but investors already are beginning to ask themselves which industries...
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Published:
While the third-quarter results may not entirely reflect the effect of the coronavirus outbreak, they will provide some picture of what’s going on with Nike.
Published:
Three Asia experts at the International Monetary Fund praised China's success at stemming the coronavirus outbreak in the country while warning of lingering economic effects.
Published:
GenMark Diagnostics stock shot up on Friday after the company announced that the FDA has issued an Emergency Use Authorization for the company’s ePlex SARS-CoV-2 test.
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Published:
BioNTech stock jumped on Tuesday and went even higher early on Wednesday. This comes after the company announced a collaboration with the pharmaceutical giant Pfizer.
Published: